JPH05132414A - Hair producing agent - Google Patents
Hair producing agentInfo
- Publication number
- JPH05132414A JPH05132414A JP3294495A JP29449591A JPH05132414A JP H05132414 A JPH05132414 A JP H05132414A JP 3294495 A JP3294495 A JP 3294495A JP 29449591 A JP29449591 A JP 29449591A JP H05132414 A JPH05132414 A JP H05132414A
- Authority
- JP
- Japan
- Prior art keywords
- group
- hair
- acid
- agent
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004209 hair Anatomy 0.000 title abstract description 12
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 15
- 150000001875 compounds Chemical class 0.000 claims abstract description 9
- 239000004480 active ingredient Substances 0.000 claims abstract description 6
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 6
- 229930195735 unsaturated hydrocarbon Natural products 0.000 claims abstract description 5
- 150000001450 anions Chemical group 0.000 claims abstract description 4
- 230000003779 hair growth Effects 0.000 claims description 13
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 125000004429 atom Chemical group 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 7
- 239000006210 lotion Substances 0.000 abstract description 6
- 239000000839 emulsion Substances 0.000 abstract description 4
- 239000000443 aerosol Substances 0.000 abstract description 3
- 239000006071 cream Substances 0.000 abstract description 3
- 239000002552 dosage form Substances 0.000 abstract description 2
- 239000000499 gel Substances 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 abstract description 2
- 150000003856 quaternary ammonium compounds Chemical class 0.000 abstract description 2
- 210000004761 scalp Anatomy 0.000 abstract description 2
- -1 heptenyl group Chemical group 0.000 description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 11
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 4
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical group I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- RZMKWKZIJJNSLQ-UHFFFAOYSA-M carpronium chloride Chemical compound [Cl-].COC(=O)CCC[N+](C)(C)C RZMKWKZIJJNSLQ-UHFFFAOYSA-M 0.000 description 2
- 229950003631 carpronium chloride Drugs 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 229960005309 estradiol Drugs 0.000 description 2
- RGXWDWUGBIJHDO-UHFFFAOYSA-N ethyl decanoate Chemical compound CCCCCCCCCC(=O)OCC RGXWDWUGBIJHDO-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 235000020710 ginseng extract Nutrition 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 230000003659 hair regrowth Effects 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- YNBADRVTZLEFNH-UHFFFAOYSA-N methyl nicotinate Chemical compound COC(=O)C1=CC=CN=C1 YNBADRVTZLEFNH-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- WJTCHBVEUFDSIK-NWDGAFQWSA-N (2r,5s)-1-benzyl-2,5-dimethylpiperazine Chemical compound C[C@@H]1CN[C@@H](C)CN1CC1=CC=CC=C1 WJTCHBVEUFDSIK-NWDGAFQWSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- YQACAXHKQZCEOI-UDCWSGSHSA-N (8s,9s,10r,13s,14s,17s)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-17-carboxylic acid Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C(O)=O)[C@@H]4[C@@H]3CCC2=C1 YQACAXHKQZCEOI-UDCWSGSHSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- AOKZLBCDXJYXOK-QXMHVHEDSA-N (z)-n-[3-(dimethylamino)propyl]docos-13-enamide Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)NCCCN(C)C AOKZLBCDXJYXOK-QXMHVHEDSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- VTHUYJIXSMGYOQ-KOORYGTMSA-N 17-hydroxyprogesterone acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 VTHUYJIXSMGYOQ-KOORYGTMSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- IPCUHQYGWOKSLR-UHFFFAOYSA-N 5-aminohexanoic acid Chemical compound CC(N)CCCC(O)=O IPCUHQYGWOKSLR-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- NEZONWMXZKDMKF-JTQLQIEISA-N Alkannin Chemical compound C1=CC(O)=C2C(=O)C([C@@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-JTQLQIEISA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- VKJGBAJNNALVAV-UHFFFAOYSA-M Berberine chloride (TN) Chemical compound [Cl-].C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 VKJGBAJNNALVAV-UHFFFAOYSA-M 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 238000011735 C3H mouse Methods 0.000 description 1
- 208000019300 CLIPPERS Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- PANKHBYNKQNAHN-JTBLXSOISA-N Crocetin Natural products OC(=O)C(\C)=C/C=C/C(/C)=C\C=C\C=C(\C)/C=C/C=C(/C)C(O)=O PANKHBYNKQNAHN-JTBLXSOISA-N 0.000 description 1
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- KKUKTXOBAWVSHC-UHFFFAOYSA-N Dimethylphosphate Chemical group COP(O)(=O)OC KKUKTXOBAWVSHC-UHFFFAOYSA-N 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical group CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- 241001071917 Lithospermum Species 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical group CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- UNNKKUDWEASWDN-UHFFFAOYSA-N alkannin Natural products CC(=CCC(O)c1cc(O)c2C(=O)C=CC(=O)c2c1O)C UNNKKUDWEASWDN-UHFFFAOYSA-N 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical group OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229960004311 betamethasone valerate Drugs 0.000 description 1
- SNHRLVCMMWUAJD-SUYDQAKGSA-N betamethasone valerate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(OC(=O)CCCC)[C@@]1(C)C[C@@H]2O SNHRLVCMMWUAJD-SUYDQAKGSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229940007061 capsicum extract Drugs 0.000 description 1
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- PANKHBYNKQNAHN-JUMCEFIXSA-N carotenoid dicarboxylic acid Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)O)C=CC=C(/C)C(=O)O PANKHBYNKQNAHN-JUMCEFIXSA-N 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940094517 chondroitin 4-sulfate Drugs 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- IVHBBMHQKZBJEU-UHFFFAOYSA-N cinchocaine hydrochloride Chemical compound [Cl-].C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCC[NH+](CC)CC)=C21 IVHBBMHQKZBJEU-UHFFFAOYSA-N 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 description 1
- PANKHBYNKQNAHN-MQQNZMFNSA-N crocetin Chemical compound OC(=O)C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C(O)=O PANKHBYNKQNAHN-MQQNZMFNSA-N 0.000 description 1
- 239000001599 crocus sativus l. flower extract Substances 0.000 description 1
- UWFYSQMTEOIJJG-FDTZYFLXSA-N cyproterone acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 UWFYSQMTEOIJJG-FDTZYFLXSA-N 0.000 description 1
- 229960000978 cyproterone acetate Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 125000003493 decenyl group Chemical group [H]C([*])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005070 decynyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C#C* 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 229960004042 diazoxide Drugs 0.000 description 1
- 229940045574 dibucaine hydrochloride Drugs 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- IUNMPGNGSSIWFP-UHFFFAOYSA-N dimethylaminopropylamine Chemical compound CN(C)CCCN IUNMPGNGSSIWFP-UHFFFAOYSA-N 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 125000005066 dodecenyl group Chemical group C(=CCCCCCCCCCC)* 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- UAUDZVJPLUQNMU-KTKRTIGZSA-N erucamide Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(N)=O UAUDZVJPLUQNMU-KTKRTIGZSA-N 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 1
- 229940031016 ethyl linoleate Drugs 0.000 description 1
- JYYFMIOPGOFNPK-AGRJPVHOSA-N ethyl linolenate Chemical compound CCOC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC JYYFMIOPGOFNPK-AGRJPVHOSA-N 0.000 description 1
- 229940090028 ethyl linolenate Drugs 0.000 description 1
- JYYFMIOPGOFNPK-UHFFFAOYSA-N ethyl linolenate Natural products CCOC(=O)CCCCCCCC=CCC=CCC=CCC JYYFMIOPGOFNPK-UHFFFAOYSA-N 0.000 description 1
- JELGPLUONQGOHF-KTKRTIGZSA-N ethyl palmitoleate Chemical compound CCCCCC\C=C/CCCCCCCC(=O)OCC JELGPLUONQGOHF-KTKRTIGZSA-N 0.000 description 1
- HQMNCQVAMBCHCO-DJRRULDNSA-N etretinate Chemical compound CCOC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C=C(OC)C(C)=C1C HQMNCQVAMBCHCO-DJRRULDNSA-N 0.000 description 1
- 229960002199 etretinate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 235000013905 glycine and its sodium salt Nutrition 0.000 description 1
- 229960002350 guaiazulen Drugs 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 125000005980 hexynyl group Chemical group 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229960001067 hydrocortisone acetate Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 229960003517 isothipendyl Drugs 0.000 description 1
- OQJBSDFFQWMKBQ-UHFFFAOYSA-N isothipendyl Chemical compound C1=CN=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 OQJBSDFFQWMKBQ-UHFFFAOYSA-N 0.000 description 1
- 229960005280 isotretinoin Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229960004393 lidocaine hydrochloride Drugs 0.000 description 1
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 1
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 229940040129 luteinizing hormone Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000005527 methyl sulfate group Chemical group 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229960001238 methylnicotinate Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N nitrate group Chemical group [N+](=O)([O-])[O-] NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M nitrite group Chemical group N(=O)[O-] IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 125000005187 nonenyl group Chemical group C(=CCCCCCCC)* 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 125000005064 octadecenyl group Chemical group C(=CCCCCCCCCCCCCCCCC)* 0.000 description 1
- YYZUSRORWSJGET-UHFFFAOYSA-N octanoic acid ethyl ester Natural products CCCCCCCC(=O)OCC YYZUSRORWSJGET-UHFFFAOYSA-N 0.000 description 1
- 125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 1
- 125000005069 octynyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C#C* 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 125000005489 p-toluenesulfonic acid group Chemical group 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000810 peripheral vasodilating agent Substances 0.000 description 1
- 229960002116 peripheral vasodilator Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 229940092385 radish extract Drugs 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 239000010667 rosehip oil Substances 0.000 description 1
- 229940076591 saffron extract Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910000275 saponite Inorganic materials 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 229960005349 sulfur Drugs 0.000 description 1
- 125000005063 tetradecenyl group Chemical group C(=CCCCCCCCCCCCC)* 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 125000005040 tridecenyl group Chemical group C(=CCCCCCCCCCCC)* 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 125000005065 undecenyl group Chemical group C(=CCCCCCCCCC)* 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は第4級アンモニウム化合
物を有効成分とする発毛剤に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a hair growth agent containing a quaternary ammonium compound as an active ingredient.
【0002】[0002]
【従来の技術】従来、養毛剤、育毛剤、発毛剤としては
塩化カルプロニウム、エストラジオール、シュエルチア
マリン、ペンタデカン酸グリセリド、人参エキスなどが
用いられてきた。一方、本発明で用いられる化合物の一
部は特開昭56−73011号公報、同59−1014
48号公報及び米国特許第4024097号公報などに
記載されているが、その発毛作用は知られていない。2. Description of the Related Art Conventionally, carpronium chloride, estradiol, chelthiamarin, pentadecanoic acid glyceride, ginseng extract and the like have been used as hair nourishing agents, hair-growth agents and hair-growth agents. On the other hand, some of the compounds used in the present invention are disclosed in JP-A-56-73011 and 59-1014.
No. 48, U.S. Pat. No. 4,024,097, etc., but its hair growth action is not known.
【0003】[0003]
【発明が解決しようとする課題】本発明の目的は、顕著
な発毛作用を有する、新しいタイプの発毛剤を提供する
ことにある。SUMMARY OF THE INVENTION An object of the present invention is to provide a new type of hair growth agent having a remarkable hair growth effect.
【0004】[0004]
【課題を解決するための手段】本発明は、The present invention comprises:
【0005】[0005]
【化2】 [Chemical 2]
【0006】(化2中、R1は炭素原子数6〜25個の
不飽和炭化水素の1価基を示し、R2,R3及びR4は同
一または異なって炭素原子数1〜4個のアルキル基を示
し、nは2〜4の整数を示し、Xは陰イオンとなる原子
または原子団を示す。)で表される化合物を有効成分と
する発毛剤である。(In the formula 2, R 1 represents a monovalent group of an unsaturated hydrocarbon having 6 to 25 carbon atoms, and R 2 , R 3 and R 4 are the same or different and have 1 to 4 carbon atoms. Is an alkyl group, n is an integer of 2 to 4, and X is an anion atom or atomic group).
【0007】本発明において、炭素原子数6〜25個の
不飽和炭化水素の1価基とは、ヘキセニル基、ヘキシニ
ル基、ヘプテニル基、オクテニル基、オクチニル基、ノ
ネニル基、デセニル基、デシニル基、ウンデセニル基、
4,8−ジメチル−3,7−ノナジエニル基、ドデセニ
ル基、トリデセニル基、テトラデセニル基、ペンタデセ
ニル基、ヘキサデセニル基、4,8,12−トリメチル
−3,7,11−トリデカトリエニル基、ヘプタデセニ
ル基、ヘプタデカジエニル基、ヘプタデカトリエニル
基、オクタデセニル基、オクタデカジイニル基、ノナデ
セニル基、ノナデカテトラエニル基、イコセニル基、イ
コサジイニル基、ヘンイコセニル基、ドコセニル基、ト
リコセニル基、テトラコセニル基、ペンタコセニル基な
ど炭素鎖中に2重結合または3重結合を1個以上含む直
鎖状または分枝鎖状の不飽和炭化水素の1価基をいう。
また、炭素原子数1〜4個のアルキル基とは、メチル
基、エチル基、プロピル基、ブチル基などの直鎖状また
は分枝鎖状のアルキル基をいう。陰イオンとなる原子ま
たは原子団としてはフッ素原子、塩素原子、臭素原子、
ヨウ素原子、硫酸基、硝酸基、亜硝酸基、硫酸メチル
基、硫酸エチル基、リン酸ジメチル基、メタンスルホン
酸基、ベンゼンスルホン酸基、p−トルエンスルホン酸
基、酢酸基などを用いることができる。In the present invention, the monovalent group of unsaturated hydrocarbon having 6 to 25 carbon atoms means hexenyl group, hexynyl group, heptenyl group, octenyl group, octynyl group, nonenyl group, decenyl group, decynyl group, Undecenyl group,
4,8-dimethyl-3,7-nonadienyl group, dodecenyl group, tridecenyl group, tetradecenyl group, pentadecenyl group, hexadecenyl group, 4,8,12-trimethyl-3,7,11-tridecatrienyl group, heptadecenyl group, Heptadecadienyl group, heptadecatrienyl group, octadecenyl group, octadecadiynyl group, nonadecenyl group, nonadecatetraenyl group, icosenyl group, icosadiynyl group, henicosenyl group, docosenyl group, tricosenyl group, tetracosenyl group, pentacosenyl group A monovalent group of a linear or branched unsaturated hydrocarbon containing at least one double bond or triple bond in the carbon chain.
In addition, the alkyl group having 1 to 4 carbon atoms refers to a linear or branched alkyl group such as a methyl group, an ethyl group, a propyl group, and a butyl group. As the atom or atomic group to be an anion, a fluorine atom, a chlorine atom, a bromine atom,
Iodine atom, sulfate group, nitrate group, nitrite group, methyl sulfate group, ethyl sulfate group, dimethyl phosphate group, methanesulfonic acid group, benzenesulfonic acid group, p-toluenesulfonic acid group, acetic acid group, etc. can be used. it can.
【0008】本発明の発毛剤は、有効成分として化2の
化合物の1種を用いてもよいし、2種以上を用いてもよ
い。その剤形としてはローション、乳液、クリーム、ゲ
ル、エアゾールなどにすることができ、これらは通常用
いられる方法(例えば、第12改正日本薬局方に規定す
る方法)に従い調製することができる。有効成分の配合
量は、製剤全量の0.05〜30重量%であり、好まし
くは0.5〜5重量%である。本発明の発毛剤は1日数
回、適量を頭皮に塗布する。The hair regrowth agent of the present invention may use one kind of the compound of Chemical formula 2 or two or more kinds thereof as an active ingredient. The dosage form may be a lotion, emulsion, cream, gel, aerosol or the like, which can be prepared according to a commonly used method (for example, the method defined in the 12th edition Japanese Pharmacopoeia). The amount of the active ingredient compounded is 0.05 to 30% by weight, preferably 0.5 to 5% by weight, based on the total amount of the preparation. The hair growing agent of the present invention is applied to the scalp in an appropriate amount several times a day.
【0009】本発明の発毛剤は、前記必須成分の他、通
常養毛剤などに用いられる物質、例えば溶媒(エチルア
ルコール、イソプロピルアルコール、1,3−ブチレン
グリコール、1,4−ブチレングリコール、プロピレン
グリコール、ジプロピレングリコール、グリセリン、ジ
グリセリン、ポリエチレングリコール、精製水など)、
ムコ多糖類(ヒアルロン酸、コンドロイチン−4−硫
酸、コンドロイチン−6−硫酸、デルマタン硫酸、ケラ
タン硫酸、ヘパラン硫酸、コンドロイチン硫酸エステル
の多硫酸エステルなど)、保存剤(パラベン、安息香酸
など)、ビタミン類[ビタミンA、ビタミンB1、ビタ
ミンB2、ビタミンB6、ビタミンC、ビタミンD、ビタ
ミンE及びそれらの誘導体(例えば、ビタミンE酢酸エ
ステルなど)]、油分(流動パラフィン、白色ワセリ
ン、固形パラフィン、セレシン、マイクロクリスタリン
ワックス、コレステロール、スクワラン、オリーブ油、
ローズヒップ油、ミンク油、ホホバ油、硬化ヒマシ油、
硬化ヤシ油、ミリスチン酸イソプロピル、カプリン酸エ
チル、カプリル酸エチル、パルミトレイン酸、パルミト
レイン酸エチル、リノール酸エチル、リノレン酸エチ
ル、オレイン酸、ステアリン酸、リノール酸、リノレン
酸、パルミチン酸、ベヘニン酸、ラウリン酸、ステアリ
ルアルコール、セチルアルコール、ラウリルアルコー
ル、オレイルアルコール、イソオクタン酸セチルな
ど)、殺菌剤[硫黄、グルコン酸クロルヘキシジン、塩
酸クロルヘキシジン、塩酸セチルピリジン、塩化デカリ
ニウム、イソプロピルメチルフェノール、第4級アンモ
ニウム塩(例えば、塩化ベンザルコニウムなど)、ヒノ
キチオールなど]、非イオン性界面活性剤(ポリオキシ
エチレン脂肪酸エステル、ポリオキシエチレンソルビタ
ン脂肪酸エステル、ソルビタン脂肪酸エステル、グリセ
リン脂肪酸エステル、ポリオキシエチレングリセリン脂
肪酸エステル、ポリグリセリン脂肪酸エステル、プロピ
レングリコール脂肪酸エステル、ポリグリセリンアルキ
ルフェニルエーテル、ポリオキシエチレン硬化ヒマシ
油、ポリオキシエチレンとポリプロピレングリコールの
共重合体など)、陰イオン性界面活性剤(N−アシルア
ミノ酸塩、N−アシルサルコシン塩、アルキルリン酸エ
ステル塩、アシルメチルタウリンなど)、陽イオン性界
面活性剤(アルキルトリメチルアンモニウム、アルキル
−N,N−ジアルキルアミノ酢酸エステルなど)、両性
界面活性剤(イミダゾリン、アミンオキシドなど)、高
分子界面活性剤(カゼインなど)、シリコーン誘導体
(シリコーンオイル、ポリオール変性シリコーン、シリ
コーン樹脂など)、増粘剤(メチルセルロース、ポリビ
ニルピロリドン、カルボキシメチルセルロース、カルボ
キシエチルセルロース、ヒドロキシプロピルセルロー
ス、カルボキシビニルポリマーなど)、粘土鉱物(モン
モリロナイト、サポナイト、ヘクトライトなど)、pH
調整剤(ジイソプロパノールアミン、クエン酸など)、
酸化防止剤(ジブチルヒドロキシトルエン、亜硫酸水素
ナトリウム、カテキン、グルクノデルタラクトンな
ど)、美白剤(アルブチン、コウジ酸など)、清涼化剤
(l−メントール、カンフルなど)、抗炎症剤(グリチ
ルレチン酸、グリチルリチン酸ジカリウム、塩化ベルベ
リン、シコニン、グアイアズレン、アラントイン、δ−
アミノカプロン酸など)、末梢血管拡張剤(ニコチン酸
メチル、ニコチン酸ベンジル、シュエルチアマリン、ミ
ノキシジル、ジアゾキシド、トウガラシエキス、カプサ
イシン、塩化カルプロニウムなど)、副腎皮質ホルモン
(酢酸ハイドロコーチゾン、吉草酸ベタメタゾンな
ど)、抗ヒスタミン剤(塩酸ジフェンヒドラミン、塩酸
イソチペンジルなど)、局所麻酔剤(塩酸ジブカイン、
塩酸リドカインなど)、角質溶解剤(尿素、サリチル酸
など)、角化調整剤[ビタミンA酸及びその誘導体(例
えば13−シス−レチノイン酸、エトレチネートな
ど)]、卵胞ホルモン(17β−エストラジオール、エ
チニルエストラジオール、エストロンなど)、黄体ホル
モン(プロゲステロン、17α−ヒドロキシプロゲステ
ロンアセテートなど)、抗アンドロゲン剤(シプロテロ
ンアセテート、4−アンドロステン−3−オン−17β
−カルボキシリックアシッドなど)、香料、金属イオン
封鎖剤、紫外線吸収剤、保湿剤(へちま抽出物、ニンジ
ンエキス、ジイソプロピルアセテート、ピロリドンカル
ボン酸、ポリグルタミン酸、ポリオキシアルキレンアル
キルグルコシドエーテル、コラーゲン、レシチン、セラ
ミド、2−アミノエタンスルホン酸、クロシン、クロセ
チンなど)、生薬エキス(かしゅうエキス、竹節人参エ
キス、ランジックエキス、サフランエキスなど)などを
本発明の効果を損なわない範囲で配合することができ
る。In addition to the above-mentioned essential components, the hair regrowth agent of the present invention is a substance that is usually used as a hair nourishing agent, such as a solvent (ethyl alcohol, isopropyl alcohol, 1,3-butylene glycol, 1,4-butylene glycol, propylene glycol). , Dipropylene glycol, glycerin, diglycerin, polyethylene glycol, purified water, etc.),
Mucopolysaccharides (hyaluronic acid, chondroitin-4-sulfate, chondroitin-6-sulfate, dermatan sulfate, keratan sulfate, heparan sulfate, polysulfate of chondroitin sulfate, etc.), preservatives (paraben, benzoic acid, etc.), vitamins [Vitamin A, Vitamin B 1 , Vitamin B 2 , Vitamin B 6 , Vitamin C, Vitamin D, Vitamin E and derivatives thereof (for example, vitamin E acetate ester)], oil (liquid paraffin, white petrolatum, solid paraffin, Ceresin, microcrystalline wax, cholesterol, squalane, olive oil,
Rosehip oil, mink oil, jojoba oil, hydrogenated castor oil,
Hardened coconut oil, isopropyl myristate, ethyl caprate, ethyl caprylate, palmitoleic acid, ethyl palmitoleate, ethyl linoleate, ethyl linolenate, oleic acid, stearic acid, linoleic acid, linolenic acid, palmitic acid, behenic acid, laurin Acid, stearyl alcohol, cetyl alcohol, lauryl alcohol, oleyl alcohol, cetyl isooctanoate), bactericide [sulfur, chlorhexidine gluconate, chlorhexidine hydrochloride, cetylpyridine hydrochloride, decalinium chloride, isopropylmethylphenol, quaternary ammonium salt (for example, , Benzalkonium chloride, etc.), hinokitiol, etc.], nonionic surfactant (polyoxyethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester, sorby Fatty acid ester, glycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyglycerin fatty acid ester, propylene glycol fatty acid ester, polyglycerin alkyl phenyl ether, polyoxyethylene hydrogenated castor oil, copolymer of polyoxyethylene and polypropylene glycol) , Anionic surfactants (N-acyl amino acid salt, N-acyl sarcosine salt, alkyl phosphate ester salt, acylmethyl taurine, etc.), cationic surfactants (alkyl trimethyl ammonium, alkyl-N, N-dialkyl) Aminoacetic acid ester, etc.), amphoteric surfactant (imidazoline, amine oxide, etc.), polymer surfactant (casein, etc.), silicone derivative (silicone oil, polyol-modified silicone) Silicone resin, etc.), thickeners (methylcellulose, polyvinylpyrrolidone, carboxymethyl cellulose, carboxyethyl cellulose, hydroxypropyl cellulose, etc. carboxyvinyl polymers), clay minerals (montmorillonite, saponite, etc. hectorite), pH
Regulators (diisopropanolamine, citric acid, etc.),
Antioxidants (dibutylhydroxytoluene, sodium bisulfite, catechin, glucnodeltalactone, etc.), whitening agents (arbutin, kojic acid, etc.), cooling agents (1-menthol, camphor, etc.), anti-inflammatory agents (glycyrrhetinic acid, Dipotassium glycyrrhizinate, berberine chloride, shikonin, guaiazulene, allantoin, δ-
Aminocaproic acid), peripheral vasodilators (methyl nicotinate, benzyl nicotinate, chelthiamarin, minoxidil, diazoxide, capsicum extract, capsaicin, carpronium chloride, etc.), adrenal cortex hormones (hydrocortisone acetate, betamethasone valerate, etc.), Antihistamines (diphenhydramine hydrochloride, isothipendyl hydrochloride, etc.), local anesthetics (dibucaine hydrochloride,
Lidocaine hydrochloride, etc.), keratolytic agent (urea, salicylic acid, etc.), keratinization regulator [vitamin A acid and its derivatives (eg 13-cis-retinoic acid, etretinate, etc.)], estrogen (17β-estradiol, ethinyl estradiol, Estrone, etc., luteinizing hormone (progesterone, 17α-hydroxyprogesterone acetate, etc.), antiandrogen (cyproterone acetate, 4-androsten-3-one-17β
-Carboxylic acid etc.), fragrance, sequestering agent, ultraviolet absorber, moisturizer (hechima extract, carrot extract, diisopropyl acetate, pyrrolidone carboxylic acid, polyglutamic acid, polyoxyalkylene alkyl glucoside ether, collagen, lecithin, ceramide , 2-aminoethanesulfonic acid, crocin, crocetin, etc.), herbal medicine extracts (kamushi extract, bamboo shoot ginseng extract, radish extract, saffron extract, etc.) can be added within a range that does not impair the effects of the present invention.
【0010】[0010]
【発明の効果】本発明により発毛効果が著しく高い発毛
剤を提供することが可能となった。EFFECTS OF THE INVENTION The present invention makes it possible to provide a hair-growth agent having a significantly high hair-growth effect.
【0011】[0011]
【実施例】以下、製造例、実施例及び試験例を挙げて本
発明を更に詳細に説明する。 (製造例)N−{3−[(Z)−13−ドコセンアミド]プロピ
ル}−N,N,N−トリメチルアンモニウム=ヨージド EXAMPLES The present invention will be described in more detail with reference to production examples, examples and test examples. (Production Example) N- {3-[(Z) -13-docosenamide] propyi
Ru} -N, N, N-trimethylammonium = iodide
【0012】[0012]
【化3】 [Chemical 3]
【0013】(1)(Z)−13−ドコセン酸10.0
gとN,N−ジメチル−1,3−ジアミノプロパン3.
6gをキシレン中、生成する水を除きながら5時間還流
した。キシレンを留去後、残渣をキシレン−n−ヘキサ
ンから再結晶することによりN−[3−(ジメチルアミ
ノ)プロピル]−(Z)−13−ドコセンアミド5.8
gを得た。 (2)上記で得た化合物2.00gとヨウ化メチル1.
34gをエタノール中、室温で3日間反応させ、生成物
をエタノールで再結晶することにより標記化合物2.3
8gを得た。 m.p.110〜112℃1 H−NMR(CDCl3) δ(ppm):0.88
(3H,t,J=6.5Hz),1.26(28H,
s),1.52〜1.70(2H,m),1.94〜
2.22(6H,m),2.31(2H,t,J=7.
5Hz),3.33〜3.47(11H,m),3.8
1〜3.92(2H,m),5.34(2H,t,J=
4.5Hz),7.16(1H,t,J=6.0Hz) 化2の化合物のうち、他の新規なものは、上記製造例に
準じて製造することができる。 (実施例1)(1) (Z) -13-docosenoic acid 10.0
g and N, N-dimethyl-1,3-diaminopropane 3.
6 g was refluxed in xylene for 5 hours while removing generated water. After distilling off xylene, the residue was recrystallized from xylene-n-hexane to give N- [3- (dimethylamino) propyl]-(Z) -13-docosenamide 5.8.
g was obtained. (2) 2.00 g of the compound obtained above and 1.
34 g was reacted in ethanol at room temperature for 3 days, and the product was recrystallized from ethanol to give the title compound 2.3.
8 g was obtained. m. p. 110 to 112 ° C. 1 H-NMR (CDCl 3 ) δ (ppm): 0.88
(3H, t, J = 6.5Hz), 1.26 (28H,
s), 1.52 to 1.70 (2H, m), 1.94 to
2.22 (6H, m), 2.31 (2H, t, J = 7.
5 Hz), 3.33 to 3.47 (11 H, m), 3.8
1-3.92 (2H, m), 5.34 (2H, t, J =
4.5 Hz), 7.16 (1H, t, J = 6.0 Hz) Of the compounds of Chemical formula 2, other novel compounds can be produced according to the above Production Examples. (Example 1)
【0014】[0014]
【表1】 [Table 1]
【0015】精製水、プロピレングリコール及びグリセ
リンに各成分を混和溶解することによりローションを調
製した。 (実施例2)A lotion was prepared by mixing and dissolving each component in purified water, propylene glycol and glycerin. (Example 2)
【0016】[0016]
【表2】 [Table 2]
【0017】精製水、エチルアルコール及び1,3−ブ
チレングリコールに各成分を混和溶解することによりロ
ーションを調製した。 (実施例3)A lotion was prepared by mixing and dissolving each component in purified water, ethyl alcohol and 1,3-butylene glycol. (Example 3)
【0018】[0018]
【表3】 [Table 3]
【0019】精製水、イソプロピルアルコール、プロピ
レングリコール及びジプロピレングリコールに各成分を
混和溶解することによりローションを調製した。 (実施例4)A lotion was prepared by mixing and dissolving each component in purified water, isopropyl alcohol, propylene glycol and dipropylene glycol. (Example 4)
【0020】[0020]
【表4】 [Table 4]
【0021】油相に油溶性成分及び界面活性剤を加温溶
解し、N−{2−[(Z)−13−ドコセンアミド]エ
チル}−N,N,N−トリメチルアンモニウム=ヨージ
ド及び水溶性成分を加温溶解した水相を添加し、乳化、
冷却しクリームを調製した。 (実施例5)The oil-soluble component and the surfactant were dissolved in the oil phase under heating to give N- {2-[(Z) -13-docosenamido] ethyl} -N, N, N-trimethylammonium = iodide and the water-soluble component. Add the aqueous phase that was dissolved by heating, emulsify,
Cooled to prepare cream. (Example 5)
【0022】[0022]
【表5】 [Table 5]
【0023】エチルアルコールに各成分を混和溶解する
ことによりローションを調製した。 (実施例6)A lotion was prepared by mixing and dissolving each component in ethyl alcohol. (Example 6)
【0024】[0024]
【表6】 [Table 6]
【0025】油相に油溶性成分及び界面活性剤を加温溶
解し、N−{2−[(9Z,12Z)−9,12−オク
タデカジエンアミド]エチル}−N,N,N−トリメチ
ルアンモニウム=ヨージド及び水溶性成分を加温溶解し
た水相を添加し、乳化、冷却し乳液を調製した。 (実施例7)原液 The oil-soluble component and the surfactant were dissolved in the oil phase under heating to give N- {2-[(9Z, 12Z) -9,12-octadecadienamide] ethyl} -N, N, N-trimethyl. An aqueous solution prepared by heating and dissolving ammonium = iodide and a water-soluble component was added, and the mixture was emulsified and cooled to prepare an emulsion. (Example 7) Stock solution
【0026】[0026]
【表7】 [Table 7]
【0027】充填剤 ジメチルエーテル 実施例6の乳液の製法に従い原液を調製し、通常の充填
法により下記エアゾール剤を調製した。 充填処方 原液:30重量%,充填剤:70重量% Filler dimethyl ether A stock solution was prepared according to the method for producing the emulsion of Example 6, and the following aerosol was prepared by a usual filling method. Filling formulation Undiluted solution: 30% by weight, Filler: 70% by weight
【0028】(試験例) 発毛効果試験 本発明化合物の発毛効果試験は、C3H系マウス(雄,
7週令)5匹を1群として用い、その背部毛をバリカン
で除毛し、その部位に1日1回、表8に示した試料0.
2mlを10日間塗布し、その後の発毛程度を下記の7
段階で肉眼により評価した。(Test Example) Hair Growth Effect Test The hair growth effect test of the compound of the present invention was carried out using C3H mice (male,
(7 weeks old) 5 animals were used as one group, and their back hairs were hair-removed with hair clippers, and the area of the sample 0.
Apply 2 ml for 10 days, and then measure the degree of hair growth after 7
It was visually evaluated at the stage.
【0029】 発毛が認められない 0点 わずかな軟毛が生えている 1点 わずかな硬毛が生えている 2点 硬毛が除毛部位の25%に生えている 3点 硬毛が除毛部位の50%に生えている 4点 硬毛が除毛部位の75%に生えている 5点 硬毛が除毛部位の100%に生えている 6点 試料塗布開始後42日後の結果を評価点の平均値で表9
に示す。No hair growth is observed 0 points A slight amount of vellus hair is grown 1 point A slight amount of bristles is grown 2 points Bristles are grown on 25% of the hair removal site 3 points Bristles are dehaired 4 points on 50% of the site 5 points on which bristles grow on 75% of the hair removal site 5 points 6 points on which bristles grow on 100% of the hair removal site 6 points Evaluation of the results 42 days after application of the sample Table 9 is the average value of the points
Shown in.
【0030】[0030]
【表8】 [Table 8]
【0031】[0031]
【表9】 [Table 9]
フロントページの続き (72)発明者 長谷川 昌宏 東京都豊島区高田3丁目24番1号 大正製 薬株式会社内 (72)発明者 畑山 勝男 東京都豊島区高田3丁目24番1号 大正製 薬株式会社内Front page continuation (72) Inventor Masahiro Hasegawa 3-24-1 Takada, Toshima-ku, Tokyo Taisho Pharmaceutical Co., Ltd. (72) Inventor Katsuo Hatayama 3-24-1 Takada, Toshima-ku, Tokyo Taisho Pharmaceutical Co., Ltd. In the company
Claims (1)
素の1価基を示し、R2,R3及びR4は同一または異な
って炭素原子数1〜4個のアルキル基を示し、nは2〜
4の整数を示し、Xは陰イオンとなる原子または原子団
を示す。)で表される化合物を有効成分とする発毛剤。Claims: (In Chemical Formula 1 , R 1 represents a monovalent group of an unsaturated hydrocarbon having 6 to 25 carbon atoms, and R 2 , R 3 and R 4 are the same or different and are alkyl groups having 1 to 4 carbon atoms. And n is 2 to
4 represents an integer of 4 and X represents an atom or an atomic group which becomes an anion. ) A hair growth agent containing a compound represented by the formula (1) as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3294495A JPH05132414A (en) | 1991-11-11 | 1991-11-11 | Hair producing agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3294495A JPH05132414A (en) | 1991-11-11 | 1991-11-11 | Hair producing agent |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH05132414A true JPH05132414A (en) | 1993-05-28 |
Family
ID=17808506
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3294495A Pending JPH05132414A (en) | 1991-11-11 | 1991-11-11 | Hair producing agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH05132414A (en) |
-
1991
- 1991-11-11 JP JP3294495A patent/JPH05132414A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2814085B2 (en) | Hair restoration | |
JPH08502509A (en) | Cosmetic composition | |
JPS5927809A (en) | Hair tonic | |
JP4940527B2 (en) | Sustainable hair growth composition | |
JPH05310549A (en) | Skin external preparation | |
KR20070087488A (en) | Hair restorer | |
EP0663812A1 (en) | Use of alkylpolyglycosides and/or o-acylated derivatives of glucose for treating hair loss. | |
US6177100B1 (en) | Cosmetic or pharmaceutical composition for the treatment of the hair and scalp | |
JPS6293215A (en) | Hair tonic | |
JPH04234805A (en) | Preparation of cosmetic composition for applying it to hair, composition obtained by this method and method for cosmetic treatment using the above described composition | |
JPH1192378A (en) | Hair tonic liquid for external use | |
JP2810040B2 (en) | Hair restorer for scalp and hair | |
JPH05139936A (en) | Hair producing agent | |
JPH05132414A (en) | Hair producing agent | |
WO1989002731A1 (en) | Hair tonic | |
WO1992009258A1 (en) | Novel use of alkanamidoammonium compound | |
WO1991011983A1 (en) | Novel use of alkanamidocarboxybetaine | |
JP2003176212A (en) | Hair cosmetic | |
JP3091267B2 (en) | Emulsified cosmetic | |
JP2969866B2 (en) | Hair growth agent | |
JPH04234804A (en) | Hair restorer | |
JPH07304634A (en) | Hair tonic | |
JP3314785B2 (en) | Minoxidil-containing hair restorer | |
JP3035017B2 (en) | Hair cosmetics | |
JPH0971513A (en) | Hair tonic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071114 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081114 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 6 Free format text: PAYMENT UNTIL: 20091114 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 6 Free format text: PAYMENT UNTIL: 20091114 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 7 Free format text: PAYMENT UNTIL: 20101114 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111114 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121114 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131114 Year of fee payment: 10 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |